植物雌激素防治围绝经期综合征
Prevention and Treatment for Perimenopausal Syndrome by Phytoestrogens
摘要: 植物雌激素是天然植物化合物，结构或功能与雌二醇相同。有雌激素或抗雌激素双向调节作用，对激素相关性疾病具有广泛防治作用。已有研究显示植物雌激素对围绝经期血管舒缩症状及绝经后的风险有益，安全而无增加阴道出血、子宫内膜增生、子宫内膜癌及乳房癌。植物雌激素是有希望的围绝经期综合征替代药物。
Abstract: Phytoestrogens are natural plant compounds that are structurally or functionally similar to estradiol, which have both estrogenic and anti-estrogenic activity, displaying a two-way regulation ability and extensive preventive and therapeutic effects on hormone-related diseases. Studies demonstrate the benefit of phytoestrogens in addressing the perimenopausal vasomotor symptoms and postmenopausal health risks. Phytoestrogens have a safe side-effect profile with no increased rates of vaginal bleeding, endometrial hyperplasia, endometrial cancer, and breast cancer. They offer a promising alternative to conventional hormone replacement therapy for perimenopausal syndrome.
文章引用：柯有甫, 曾乐谦, 高文谦, 魏克民, 郑军献. 植物雌激素防治围绝经期综合征[J]. 中医学, 2013, 2(3): 23-25. http://dx.doi.org/10.12677/TCM.2013.23006

参考文献

[1] D. F. Romagnolo, O. I. Selmin. Flavonoids and cancer preven- tion: a review of the evidence. Journal of Nutrition in Gerontol- ogy and Geriatrics, 2012, 31(3): 206-238.
[2] 朱迪娜, 王磊, 王思彤等. 植物雌激素的研究进展[J]. 中草药, 2012, 43(7): 1422-1429.
[3] 赵洁, 侯连兵. 植物雌激素的活性成分及其生物活性研究进展[J]. 中药材, 2005, 28(6): 524-526.
[4] P. Collins, G. Rosano, C. Casey, et al. Management of cardiovas- cular risk in the perimenopausal women: A consensus statement of European cardiologists and gynecologists. Climacteric, 2007, 10(6): 508-526.
[5] J. Marjoribanks, C. Farquhar, H. Roberts, et al. Long term hor- mone therapy for perimenopausal and postmenopausal women. Cochrane Database of Systematic Reviews, 2012, 7: CD004143.
[6] V. Colpani, K. Oppermann and P. M. Spritzer. Association be- tween habitual physical activity and lower cardiovascular risk in premenopausal, perimenopausal, and postmenopausal women: A population-based study. Menopause, 2013, 20(5): 525-531.
[7] Q. S. Li, C. Y. Li, Z. L. Li and H. L. Zhu. Genistein and its syn- thetic analogs as anticancer agents. Anti-Cancer Agents in Me- dicinal Chemistry, 2012, 12(3): 271-281.
[8] S. Palacios, V. W. Henderson, N. Siseles, et al. Age of meno- pause and impact of climacteric symptoms by geographical re- gion. Climacteric, 2010, 13(5): 419-428.
[9] L. A. Ramsey, B. S. Ross and R. G. Fischer. Phytoestrogens and the management of menopause. Advanced Nursing Practice, 1999, 7(5): 26-30.
[10] A. A. Ewies. Phytoestrogens in the management of the meno- pause: Up-to-date. Obstetrical & Gynecological Survey, 2002, 57(5): 306-313.
[11] M. J. Leach, V. Moore. Black cohosh (Cimicifuga spp.) for me- nopausal symptoms. Cochrane Database of Systematic Reviews, 2012, 9: CD007244.
[12] C. B. Tempfer, G. Froese, G. Heinze, et al. Side effects of phy- toestrogens: A meta-analysis of randomized trials. American Journal of Medicine, 2009, 122(10): 939-946.
[13] L. N. Anderson, M. Cotterchio, B. A. Boucher, et al. Phytoes- trogen intake from foods, during adolescence and adulthood, and risk of breast cancer by estrogen and progesterone receptor tu- mor subgroup among Ontario women. International Journal of Cancer, 2013, 132(7): 1683-1692.
[14] T. Chiyomaru, S. Yamamura, S. Fukuhara, et al. Genistein up- regulates tumor suppressor microRNA-574-3p in prostate can- cer. PLoS One, 2013, 8(3): e58929.
[15] H. Chang, Q. Xie, Q. Y. Zhang, et al. Flavonoids, flavonoid subclasses and breast cancer risk: A meta-analysis of epidemi- ologic studies. PLoS One, 2013, 8(1): e54318.